Philadelphia medical technology company Proscia raised a $37 million Series C funding round, doubling what it has taken in from investors since its inception eight years ago.
Founded in 2014 by a team of biomedical engineers from Johns Hopkins University and the University of Pittsburgh, the company uses artificial intelligence to improve how pathologists diagnose cancer.
Read the full article at: www.bizjournals.com
